Has Stanley Hollmig, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,362 in general payments to Stanley Hollmig, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanley Hollmig, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanley Hollmig, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanley Hollmig, MD

MOHS-Micrographic Surgery · Austin, TXNPI 1033437835

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,000 of the $2,362 with a category attached, or 84.7%. Lumenis, Inc accounts for 95.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $2,013 and has fallen 97.3% since, to $53 in 2023.

$2,362in general payments, 2019–2025

Across 6 payments — averaging $393.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lumenis, Inc$2K
AbbVie$53
Merz North America, Inc.$51

What the payments were for

Speaking & faculty fees$2,00085%
Food & beverage$36215%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lumenis, Inc	2	$2,258
AbbVie	2	$53
Merz North America, Inc.	2	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Lumenis Pulse 120H$2,000

How this compares

$2,362 in reported general payments places this provider in the 55th percentile of 109 mohs-micrographic surgery providers in Texas.

See all mohs-micrographic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$393,247

Medicare patients

313

Services billed

1,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	216	$1,065
ValacyclovirValacyclovir Hcl	28	$391
Clindamycin Hcl	38	$262
Oxycodone Hcl	56	$211
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	37	$183
Diazepam	16	$10

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Austin

Jessica DietertAustin$6K
Nicholas SnavelyAustin$4K
Chelsey StraightAustin$2K
Aaron FarbergRockwall$1.5M
Suneel ChilukuriBellaire$288K
Ryan O QuinnSan Antonio$167K
Paul FriedmanHouston$131K
Brent SpencerFrisco$45K
Julie CroleyThe Woodlands$30K
Kayla McNieceBellaire$13K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →